The main objective is to assess the measurement characteristics (validity, reproducibility) and the invariance of EGOMAC scale in a population of consultants in diabetology, cardiology and rheumatology hospital and liberal and hospital oncology and Infectious disease, by following the evolution of patient compliance at D0 and D15. The second objective is to assess the sensitivity to change of scale EGOMAC following developments compliance 3 months.
During a routine appointment (D0), the patient filled a newsletter and a questionnaire to complete. The doctor collects medical informations for the case report form. At the end of the first consultation (D0), an additional EGOMAC scale and a stamped envelope is delivered to the patient by asking him to fill that scale to 15 days and return it by Post Office (reproducibility study). Finally, a new scale will be addressed to the patient at the end of 3 months, which will return by Post Office too (stability study).
Study Type
OBSERVATIONAL
Enrollment
397
Central hospital
Nancy, France
EGOMAC questionnaire
Time frame: baseline
Change in EGOMAC questionnaire
Time frame: 15 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.